Comparison between urinary pyridinium cross-links and hydroxylysine glycosides in monitoring the effects of ovariectomy and 17β-estradiol replacement in aged rats

A. Pecile, C. Netti, V. Sibilia, I. Villa, G. Calori, R. Tenni, M. Coluzzi, G. L. Moro, A. Rubinacci

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This study was undertaken to assess the sensitivity of hydroxylysylpyridinoline (HP), lysylpyridinoline (LP), galactosylhydroxylysine (GHyl) and glucosylgalactosylhydroxylysine (GGHyl) to monitor bone response to estrogen deficiency and replacement by comparing their excretory patterns in ovariectomized aged (11-14 months old) rats. The ovariectomized (OVX) rats were randomized into two groups: (1) OVX plus vehicle; (2) OVX plus 17β-estradiol (17-βE, 10 μg/kg, s.c., 4 days/week). Treatment with 17-βE started immediately after OVX and continued for 60 days. The collagen catabolites were measured in urine for 1 month before OVX and thereafter for 60 days. In temporal coincidence with urine collection, bone area and bone mineral density (BMD) of lumbar vertebrae, femoral diaphysis and distal metaphysis were measured by dual-energy X-ray absorptiometry. In the untreated rats, BMD of the femoral metaphysis and lumbar Vertebrae decreased significantly and the urinary excretion of LP, HP, GHyl and GGHyl increased with different patterns. In the treated rats, 17-βE replacement prevented the increment in LP excretion, partially prevented the increase in HP excretion, but had no effect on the excretion of GHyl and GGHyl. In conclusion pyridinolines and glycosides have different sensitivities to the bone response to OVX. Glycoside excretion after OVX also reflects metabolic processes not strictly related to bone loss and, in contrast with LP, is not sensitive to estrogen replacement.

Original languageEnglish
Pages (from-to)383-390
Number of pages8
JournalJournal of Endocrinology
Volume150
Issue number3
Publication statusPublished - Sep 1996

Fingerprint

Ovariectomy
Estradiol
Bone and Bones
Lumbar Vertebrae
Estrogen Replacement Therapy
Glycosides
Thigh
Bone Density
Diaphyses
Urine Specimen Collection
Photon Absorptiometry
Collagen
Urine
pyridinoline
deoxypyridinoline
hydroxylysine glycoside
glucosylgalactosylhydroxylysine
galactosylhydroxylysine
Therapeutics

ASJC Scopus subject areas

  • Endocrinology

Cite this

Comparison between urinary pyridinium cross-links and hydroxylysine glycosides in monitoring the effects of ovariectomy and 17β-estradiol replacement in aged rats. / Pecile, A.; Netti, C.; Sibilia, V.; Villa, I.; Calori, G.; Tenni, R.; Coluzzi, M.; Moro, G. L.; Rubinacci, A.

In: Journal of Endocrinology, Vol. 150, No. 3, 09.1996, p. 383-390.

Research output: Contribution to journalArticle

@article{08f2e5d1650f49e488dfc28a23c80770,
title = "Comparison between urinary pyridinium cross-links and hydroxylysine glycosides in monitoring the effects of ovariectomy and 17β-estradiol replacement in aged rats",
abstract = "This study was undertaken to assess the sensitivity of hydroxylysylpyridinoline (HP), lysylpyridinoline (LP), galactosylhydroxylysine (GHyl) and glucosylgalactosylhydroxylysine (GGHyl) to monitor bone response to estrogen deficiency and replacement by comparing their excretory patterns in ovariectomized aged (11-14 months old) rats. The ovariectomized (OVX) rats were randomized into two groups: (1) OVX plus vehicle; (2) OVX plus 17β-estradiol (17-βE, 10 μg/kg, s.c., 4 days/week). Treatment with 17-βE started immediately after OVX and continued for 60 days. The collagen catabolites were measured in urine for 1 month before OVX and thereafter for 60 days. In temporal coincidence with urine collection, bone area and bone mineral density (BMD) of lumbar vertebrae, femoral diaphysis and distal metaphysis were measured by dual-energy X-ray absorptiometry. In the untreated rats, BMD of the femoral metaphysis and lumbar Vertebrae decreased significantly and the urinary excretion of LP, HP, GHyl and GGHyl increased with different patterns. In the treated rats, 17-βE replacement prevented the increment in LP excretion, partially prevented the increase in HP excretion, but had no effect on the excretion of GHyl and GGHyl. In conclusion pyridinolines and glycosides have different sensitivities to the bone response to OVX. Glycoside excretion after OVX also reflects metabolic processes not strictly related to bone loss and, in contrast with LP, is not sensitive to estrogen replacement.",
author = "A. Pecile and C. Netti and V. Sibilia and I. Villa and G. Calori and R. Tenni and M. Coluzzi and Moro, {G. L.} and A. Rubinacci",
year = "1996",
month = "9",
language = "English",
volume = "150",
pages = "383--390",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "BioScientifica Ltd.",
number = "3",

}

TY - JOUR

T1 - Comparison between urinary pyridinium cross-links and hydroxylysine glycosides in monitoring the effects of ovariectomy and 17β-estradiol replacement in aged rats

AU - Pecile, A.

AU - Netti, C.

AU - Sibilia, V.

AU - Villa, I.

AU - Calori, G.

AU - Tenni, R.

AU - Coluzzi, M.

AU - Moro, G. L.

AU - Rubinacci, A.

PY - 1996/9

Y1 - 1996/9

N2 - This study was undertaken to assess the sensitivity of hydroxylysylpyridinoline (HP), lysylpyridinoline (LP), galactosylhydroxylysine (GHyl) and glucosylgalactosylhydroxylysine (GGHyl) to monitor bone response to estrogen deficiency and replacement by comparing their excretory patterns in ovariectomized aged (11-14 months old) rats. The ovariectomized (OVX) rats were randomized into two groups: (1) OVX plus vehicle; (2) OVX plus 17β-estradiol (17-βE, 10 μg/kg, s.c., 4 days/week). Treatment with 17-βE started immediately after OVX and continued for 60 days. The collagen catabolites were measured in urine for 1 month before OVX and thereafter for 60 days. In temporal coincidence with urine collection, bone area and bone mineral density (BMD) of lumbar vertebrae, femoral diaphysis and distal metaphysis were measured by dual-energy X-ray absorptiometry. In the untreated rats, BMD of the femoral metaphysis and lumbar Vertebrae decreased significantly and the urinary excretion of LP, HP, GHyl and GGHyl increased with different patterns. In the treated rats, 17-βE replacement prevented the increment in LP excretion, partially prevented the increase in HP excretion, but had no effect on the excretion of GHyl and GGHyl. In conclusion pyridinolines and glycosides have different sensitivities to the bone response to OVX. Glycoside excretion after OVX also reflects metabolic processes not strictly related to bone loss and, in contrast with LP, is not sensitive to estrogen replacement.

AB - This study was undertaken to assess the sensitivity of hydroxylysylpyridinoline (HP), lysylpyridinoline (LP), galactosylhydroxylysine (GHyl) and glucosylgalactosylhydroxylysine (GGHyl) to monitor bone response to estrogen deficiency and replacement by comparing their excretory patterns in ovariectomized aged (11-14 months old) rats. The ovariectomized (OVX) rats were randomized into two groups: (1) OVX plus vehicle; (2) OVX plus 17β-estradiol (17-βE, 10 μg/kg, s.c., 4 days/week). Treatment with 17-βE started immediately after OVX and continued for 60 days. The collagen catabolites were measured in urine for 1 month before OVX and thereafter for 60 days. In temporal coincidence with urine collection, bone area and bone mineral density (BMD) of lumbar vertebrae, femoral diaphysis and distal metaphysis were measured by dual-energy X-ray absorptiometry. In the untreated rats, BMD of the femoral metaphysis and lumbar Vertebrae decreased significantly and the urinary excretion of LP, HP, GHyl and GGHyl increased with different patterns. In the treated rats, 17-βE replacement prevented the increment in LP excretion, partially prevented the increase in HP excretion, but had no effect on the excretion of GHyl and GGHyl. In conclusion pyridinolines and glycosides have different sensitivities to the bone response to OVX. Glycoside excretion after OVX also reflects metabolic processes not strictly related to bone loss and, in contrast with LP, is not sensitive to estrogen replacement.

UR - http://www.scopus.com/inward/record.url?scp=0029784117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029784117&partnerID=8YFLogxK

M3 - Article

C2 - 8882157

AN - SCOPUS:0029784117

VL - 150

SP - 383

EP - 390

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 3

ER -